COVID-19 infection
Conditions
Interventions
treatment group:Sequential treatment with two or more traditional Chinese medicine compound formulas
control group:Standardized treatment of monovir capsules
Sponsors
Tongde Hospital of Zhejiang Provincial
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.To the diagnostic criteria of moderate COVID-19 infection. 2.To the diagnostic criteria of COVID-19 infection with cold dampness obstructing lung syndrome, dampness toxin stagnating lung syndrome, and epidemic toxin hurting yin syndrome. 3. To take Paxlovid or Monapivir standardized treatment according to the Diagnosis and Treatment Plan for novel coronavirus Infection (Tenth Edition on Trial). 4. To take two or more traditional Chinese medicine prescriptions during the follow-up period. 5. To have high-risk groups with advanced age, obesity, underlying diseases, etc. 6. To possess communication and certain cognitive abilities. 7. Not to participating in clinical studies of other drugs within three months.
Exclusion criteria
Exclusion criteria: 1. To with obvious communication or other motor disorders. 2. Pregnant, lactating women, and mentally ill patients who are difficult to control. 3. To with drug allergies in this study. 4. To undergo other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical cure rate; | — |
Countries
China
Contacts
Public ContactHuang fei hua
Tongde Hospital of Zhejiang Provincial
Outcome results
None listed